State Street Corporation 13D and 13G filings for Catalyst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 12:14 pm Sale |
2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
5,685,330 4.800% |
-1,102,002 (-16.24%) |
Filing |
| 2024-01-25 10:09 am Sale |
2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
6,787,332 6.370% |
-1,085,982 (-13.79%) |
Filing |
| 2023-02-08 10:44 am Purchase |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
7,873,314 7.570% |
2,822,325 (+55.88%) |
Filing |
| 2022-02-09 12:23 pm Sale |
2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
5,050,989 4.900% |
-1,062,941 (-17.39%) |
Filing |
| 2021-02-05 12:32 pm Sale |
2020-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
6,113,930 5.900% |
-1,304,365 (-17.58%) |
Filing |